Breast CAncer

Updated Guidelines Issued for ER, PgR Testing in Breast Cancer

Publish Date January 27, 2020

Clinicians should be prepared to discuss limited data for benefit of endocrine tx in ER-low positive cases.

Multidimensional Factors Underlying Ability to Work After Primary Treatment for Nonmetastatic Breast Cancer

By

Susan Moench, PhD, PA-C

Publish Date January 27, 2020

A study evaluated contributions of physical and psychological symptoms, and pre-existing comorbidities to employment status following treatment for breast cancer.

No Link Found Between Hepatitis C Infection and Extrahepatic Cancers

By

Leah Lawrence

Publish Date January 23, 2020

A study of an Asian population failed to find a link between the virus and malignancies outside of the liver.

Immunotherapy for the Treatment of Breast Cancer: Emerging New Data

Publish Date January 17, 2020

[Breast Cancer: Targets and Therapy] In this report, the researchers review the treatment of triple-negative breast cancer and specifically shed light on advances in immunotherapy and newly approved drugs for this challenging-to-manage disease.

More Education Needed on Breast Density and Screening Choices

Publish Date January 13, 2020

Women largely do not know breast density ups risk for breast cancer even in U.S. states with notification.

Dense Breast Notifications May Not Be Having Intended Impact

Publish Date January 7, 2020

Few differences seen between women residing in states that require notifications and those who do not.

Deep Learning Model Predicts Future Breast Cancer Risk

Publish Date January 3, 2020

False-negative rate lower for age-adjusted deep learning risk score versus density-based models.

RT for DCIS Ups Mortality Risk in Invasive Second Breast Cancer

Publish Date January 3, 2020

Rates of mortality for invasive second breast cancer higher in those with prior radiotherapy for DCIS.

Enhertu Approved to Treat HER2-Positive Breast Cancer Following 2 or More Prior Anti-HER2 Therapies

By

Brian Park, PharmD

Publish Date January 2, 2020

The US FDA has granted accelerated approval to Enhertu for the treatment of some adults with unresectable or metastatic HER2-positive breast cancer.

Removing Barriers to Optimal Breast Cancer Screening May Improve Overall Survival

By

John Schieszer

Publish Date January 1, 2020

The researchers looked at what barriers may be contributing to low screening rates among women in Pima County in Southern Arizona.